Viewing nowEsomeprazole Magnesium Delayed Release Capsule 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 10.85mg
Prescription medication
Youyoung Pharmaceutical Co., Ltd.

MFDS item code 202101872 · Approved 2021.02.24 · Insurance code 648204420
Treatment and prevention of recurrence of gastroesophageal reflux disease (reflux esophagitis)
Gastroesophageal reflux disease is a condition that causes discomfort due to the regurgitation of stomach contents into the esophagus. This medication is used for the treatment of erosive reflux esophagitis and improves symptoms by alleviating damage to the esophageal mucosa. Furthermore, it is utilized as a long-term maintenance therapy to prevent recurrence after treatment. This helps effectively manage symptoms and improve patients' quality of life. Therefore, it is used for the treatment and prevention of recurrence of gastroesophageal reflux disease.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Take 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the medicine for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this medicine. 6. Older adults: No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Take 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the medicine for an additional 4 weeks. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in certain patients. Patients with allergies to this medication or its components, those who have had hypersensitivity reactions to benzimidazoles, patients taking specific antiviral drugs such as atazanavir and nelfinavir, nursing women, and patients taking drugs containing rilpivirine should not use this medication. This medication can cause side effects such as gastrointestinal disturbances, headache, dizziness, etc. Rarely, serious reactions such as blood abnormalities, liver dysfunction, and skin rashes have been reported. Prolonged use may lead to electrolyte abnormalities, such as hypomagnesemia, requiring regular monitoring. As this medication suppresses gastric acid, the risk of gastrointestinal bacterial infections may slightly increase. In particular, hospitalized patients may have an increased risk of diarrhea due to Clostridium difficile; therefore, consultation with a doctor is necessary if diarrhea persists. Patients taking this medication long-term may have an increased risk of fractures; hence, monitoring and preventive measures are essential if there is a risk of osteoporosis. This medication can interact with other drugs; thus, if taking other medications, especially anticoagulants, antiviral drugs, anticonvulsants, or antidepressants, it is crucial to inform your physician or pharmacist. Co-administration can alter the effectiveness of the drugs or increase the risk of side effects. During pregnancy, data on the safety of this drug is limited; therefore, it should be used with caution during pregnancy, and it is advisable for nursing women not to take this medication. In the event of overdose, there are no specific antidotes, and symptomatic relief and supportive care are required. This medication is not removed by dialysis, so immediate consultation with healthcare professionals is necessary in the case of overdose. Store this medication out of the reach of children; transferring it to another container may not maintain quality and should be avoided.
Diarrhea, dyspepsia, nausea, gastric ulcer, headache, dizziness, increase in aspartate aminotransferase, increase in alanine aminotransferase, increase in blood creatine phosphokinase, increase in blood alkaline phosphatase, increase in blood lactate dehydrogenase, joint dislocation, arthralgia, influenza, urticaria, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, altered perception, drowsiness, taste disturbance, blurred vision, dizziness, bronchospasm, pancreatitis, abdominal pain, constipation, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increase in liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular rash, drug reaction with eosinophilia and systemic symptoms, fracture, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, rigidity, flushing, hypertension, tachycardia, thyroid goiter, irritable bowel syndrome, worsening constipation, dysphagia, gastrointestinal developmental disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased blood gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disturbance, tremor, visual field defect, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric antral polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, elevated creatine kinase, increased serum and urine myoglobin, cutaneous lupus erythematosus, systemic lupus erythematosus, rash, arthralgia, cytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized pustular rash
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is essential to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness and safety.
A controlled-release hard capsule with a pink upper part and a white lower part containing white to light yellow round pellets.
14 capsules/PTP [7 capsules/PTPX2], 30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 10.85mg
Prescription medication
Youyoung Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.